AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
BofA notes that AstraZeneca (AZN) shares are down greater than 10% in the last few days on the back of China concerns around the ongoing ...
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.
Shares of AstraZeneca (AZN) are lower as more headlines emerge on the scope of the ongoing China probe of the company’s China president, ...
AstraZeneca has emphasized its continued commitment to delivering medicines in China, despite speculative media reports about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback